Yale Technologies
Yale Ventures oversees Yale's technology transfer office, protecting and licensing the intellectual property developed at Yale, and helping to bring breakthroughs to market as products and services that can make a difference in the world.
Yale Technologies Available for Licensing
Yale Principal Investigator Pitches and Presentations
Search (Pitches)
Search (Pitches)
-
Development of camostat-related compounds for COVID-19 and other coronavirus infections
Joseph Vinetz, MD, FACP, FIDSA, FASTMH, BS -
-
Direct intralesional mTOR inhibition for targeted treatment of sporadic and syndromic venous and lymphatic malformations
Naiem Nassiri, MD, RPVI -
Stilbene a new antibiotic class for topical and systemic administration
Jason Crawford, PhD, Associate Professor of Chemistry and Associate Professor of Microbial Pathogenesis -
Fyn & Pyk2 Kinase Inhibition for Alzheimer's Disease
Stephen Strittmatter, M.D., Ph.D. -
Target Site Blocker (TSB) of the IL-17A-miR466I-3p iInteraction Prevents Progressive and Relapsing Remitting EAE
Jeffrey Bender, M.D. -
NCS1 - A New Target for Mood Disorders and Wolfram Syndrome
Barbara Ehrlich, Ph.D. -
Cell Permeable Miniature Proteins
Alanna Schepartz, Ph.D. -
PremieBreathe: Low-Cost Breathing Aid for Newborns
Anjelica Gonzalez, PhD -
A Probiotic Gene Cassette for Ulcerative Colitis Treatment
Jason Crawford, PhD, Associate Professor of Chemistry and Associate Professor of Microbial Pathogenesis